PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24978614-4	2014	We have found Kenpaullone, a potent CDK1, CDK2 and CDK5 inhibitor, as new enhancer for iTreg cell differentiation.	kenpaullone	14-25	cyclin dependent kinase 1	Homo sapiens	36-40	
14698171-2	2004	Among the novel structures, 1-azakenpaullone was found to act as a selective GSK-3beta versus CDK1 inhibitor.	kenpaullone	28-44	cyclin dependent kinase 1	Homo sapiens	94-98	
10363974-2	1999	9-Bromo-7,12-dihydro-indolo[3,2-d][1]benzazepin-6(5H)-one, NSC-664704 (kenpaullone), is reported here to be a potent inhibitor of CDK1/cyclin B (IC50, 0.4 microM).	kenpaullone	0-57	cyclin dependent kinase 1	Homo sapiens	130-134	
10363974-2	1999	9-Bromo-7,12-dihydro-indolo[3,2-d][1]benzazepin-6(5H)-one, NSC-664704 (kenpaullone), is reported here to be a potent inhibitor of CDK1/cyclin B (IC50, 0.4 microM).	kenpaullone	71-82	cyclin dependent kinase 1	Homo sapiens	130-134	
10363974-6	1999	Analogues of kenpaullone, in particular 10-bromopaullone (NSC-672234), also inhibited various protein kinases including CDKs.	kenpaullone	13-24	cyclin dependent kinase 1	Homo sapiens	120-124	
10363974-8	1999	Kenpaullone represents a novel chemotype for compounds that preferentially inhibit CDKs.	kenpaullone	0-11	cyclin dependent kinase 1	Homo sapiens	83-87